About Anton Mat

This author has not yet written his bio.
Meanwhile let's just say that we are proud Anton Mat contributed with 5 entries.

Entries by Anton Mat

ISA to Present at Business Conferences in May 2022

ISA Pharmaceuticals announces the start of clinical trial using its novel AMPLIVANT® technology

Long term study confirms efficacy of our T-cell activating immunotherapy in combination with checkpoint inhibitor

ISA Pharmaceuticals to Attend Multiple In Person Conferences in Early 2022